Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity

Leishamaniasis is a neglected disease caused by over 20 Leishmania species, occurring in more than a hundred countries. Miltefosine (hexadecylphosphocholine) is the single oral drug used in treatment for leshmaniases, including cases of infections resistant to pentavalent antimony. Our group has rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelo-Branco, Patrícia Valéria, Alves, Hugo José, Pontes, Raissa Lacerda, Maciel-Silva, Vera Lucia, Ferreira Pereira, Silma Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304451/
https://www.ncbi.nlm.nih.gov/pubmed/30578864
http://dx.doi.org/10.1016/j.ijpddr.2018.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304451/
https://www.ncbi.nlm.nih.gov/pubmed/30578864
http://dx.doi.org/10.1016/j.ijpddr.2018.12.002

Ejemplares similares